Olek Elizabeth A

Avg. Two Year Performance

(6%) Avg. Purchase Return
(3%) Compound
64% Avg. Sale Return
28% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(50%)(58%)(37%)(32%)(6%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return6%(5%)31%9%64%
Sale Success Rate1 of 10 of 11 of 11 of 11 of 1
Drugs » Biotechnology

SVP and CMO:

Holdings: 2.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

SR VP, CLINICAL SCIENCE:

Holdings: 193.28K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--